medcareworld’s modern day slavery and Human trafficking statement 2023 - 2024
These are the steps medcareworld have taken and continue to take to understand and minimise the potential risk of modern slavery in its business and supply chains.
This statement is published in line with section 54(1) of the Modern Slavery Act 2015.
medcareworld offers innovative and integrated medical support solutions that deliver flexible, outcome-focussed, and measurable results for our NHS clients. We have been providing medical insourcing solutions since 2015 and we have worked with numerous NHS Trusts nationwide.
We believe that modern medical services should be managed and delivered in such a way as to give patients access to the most appropriate tailored healthcare and to facilitate their seamless “flow" along the treatment pathway. We provide high quality clinical, technical, and administrative support that takes improving patient outcomes as the absolute starting point.
Our teams of specialist clinicians and digital systems integrate with existing NHS Trust services to streamline patient pathways, optimise the patient experience and to deliver lower overall costs.
Detailed analysis over many years has shown that removing back-logs and improving patient flow across the total health system:
improves the patient experience.
improves clinical outcomes
eliminates waits and delays
saves time and money by removing duplication of effort
ultimately is more cost effective
Bespoke clinical, administrative, and digital solutions
We provide solutions that are tailored to the needs of individual NHS Trusts but that are always solidly patient-centric.
We work collaboratively with NHS Trusts to ensure that we understand specific needs and then deliver high quality and individually tailored solutions to patient flow problems.
Our services are built on a robust clinical and managerial governance framework that strives for excellence.
Our commitment to the principles of the Modern Slavery Act 2015
medcareworld is committed to the principles of the Modern Slavery Act 2015 and the abolition of modern slavery and human trafficking.
As an equal opportunity’s employer, we're committed to creating and ensuring a non-discriminatory and respectful working environment for our staff. We want all our staff to feel confident that they can expose wrongdoing without any risk to themselves.
Our recruitment and people management processes are designed to ensure that all prospective employees are legally entitled to work in the UK and to safeguard employees from any abuse or coercion.
We do not enter business with any organisation, in the UK or abroad, which knowingly supports or is found to be involved in slavery, servitude and forced or compulsory labour.
Our supply chain
Due to the nature of our business, we assess ourselves to have a low risk of modern slavery in our business and supply chains.
Our policies in relation to the Modern Slavery Act 2015
The following policies are available to all staff through the medcareworld intranet:
Code of conduct
Speak Up policy.
Bullying and harassment policy
Diversity and inclusion policy
Recruitment and selection policy
Embedding the principles
We will continue to embed the principles through:
providing awareness training to staff on the Modern Slavery Act 2015 and informing them of the appropriate action to take if they suspect a case of slavery or human trafficking.
ensuring staff involved in procurement activity are aware of and follow modern slavery procurement guidance on GOV.UK
ensuring that consideration of the modern slavery risks and prevention are added to medcareworld’s policy review process as an employer.
making sure medcareworld and our procurement strategies and contract terms and conditions include references to modern slavery and human trafficking.
continuing to take action to embed a zero-tolerance policy towards modern slavery
ensuring that staff involved in buying or procurement and the recruitment and deployment of workers receive training on modern slavery and ethical employment practices.
This statement has been approved by Dr Prem Premchand - CEO and Medical Director, for the financial year ending 31 March 2024.
This statement will be reviewed and updated every year.